Lucinda Crabtree

Directeur Financier/CFO chez OXFORD BIOMEDICA PLC

47 ans

Health Technology

Consumer Services

Profil

Lucinda Crabtree currently works at Oxford Biomedica Plc, as Chief Financial Officer & Director from 2024.
Dr. Crabtree also formerly worked at Autolus Therapeutics Plc, as Chief Financial Officer from 2020 to 2023 and MorphoSys AG, as Chief Financial Officer from 2023 to 2024.
Dr. Crabtree received her undergraduate degree and doctorate degree from University College London.

Postes actifs de Lucinda Crabtree

Sociétés	Poste	Début
OXFORD BIOMEDICA PLC	Directeur Financier/CFO	02/09/2024

Tous les postes actifs de Lucinda Crabtree

Anciens postes connus de Lucinda Crabtree

Sociétés	Poste	Fin
MORPHOSYS AG	Directeur Financier/CFO	06/06/2024
AUTOLUS THERAPEUTICS PLC	Directeur Financier/CFO	07/08/2023

Voir l'expérience en détail de Lucinda Crabtree

Formation de Lucinda Crabtree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Lucinda Crabtree

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées	4
MorphoSys AG MorphoSys AG BiotechnologyHealth Technology Manufactures pharmaceutical products and provides research and development services	Health Technology
Oxford Biomedica Plc Oxford Biomedica Plc BiotechnologyHealth Technology Operates as a contract development and manufacturing organization which provides viral vectors to pharmaceutical and biotechnology clients in cell and gene therapy fields	Health Technology
University College London University College London Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Autolus Therapeutics Plc Autolus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of gene therapies	Health Technology